✦ LIBER ✦

Clinical studies with ropinirole in Parkinson’s disease and RLS

✍ Scribed by Wolfgang H. Jost; Dieter Angersbach; Olivier Rascol

Publisher: Springer
Year: 2006
Tongue: English
Weight: 225 KB
Volume: 253
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-006-4004-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discontinuation of ropinirole and pramip

Discontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials

✍ Maurits E. L. Arbouw; Kris L. L. Movig; Henk-Jan Guchelaar; Petra J. E. Poels; J 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 149 KB

High-dose therapy with ropinirole in pat

High-dose therapy with ropinirole in patients with Parkinson's disease

✍ M. Müngersdorf; U. Sommer; M. Sommer; H. Reichmann 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 106 KB

An overnight switch to ropinirole therap

An overnight switch to ropinirole therapy in patients with Parkinson's disease

✍ M. Canesi; A. Antonini; C. B. Mariani; S. Tesei; A. L. Zecchinelli; M. Barichell 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 52 KB

Slower progression of Parkinson's diseas

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

✍ Alan L. Whone; Ray L. Watts; A. Jon Stoessl; Margaret Davis; Sven Reske; Claude 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Lack of pharmacokinetic interaction betw

Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease

✍ C. Thalamas; A. Taylor; C. Brefel-Courbon; S. Eagle; K. Fitzpatrick; O. Rascol 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 95 KB

PREPARED: Comparison of prolonged and im

PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease

✍ Fabrizio Stocchi; Luigi Giorgi; Brian Hunter; Anthony HV Schapira 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

## Abstract Background: PREPARED was a randomized, parallel‐group, double‐blind, multicenter study to evaluate the efficacy of adjunctive ropinirole prolonged release (PR) versus immediate release (IR) in patients with advanced Parkinson's disease (PD). Methods: Patients received once‐daily PR (2–2